BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

549 related articles for article (PubMed ID: 19877785)

  • 1. Use of 5-aminolevulinic acid for visualization and resection of a benign pediatric brain tumor.
    Ruge JR; Liu J
    J Neurosurg Pediatr; 2009 Nov; 4(5):484-6. PubMed ID: 19877785
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Temporal lobe pleomorphic xanthoastrocytoma and chronic epilepsy: long-term surgical outcomes.
    Wallace DJ; Byrne RW; Ruban D; Cochran EJ; Roh D; Whisler WW
    Clin Neurol Neurosurg; 2011 Dec; 113(10):918-22. PubMed ID: 21741164
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Use of 5-aminolevulinic acid for the confirmation of deep-seated brain tumors during stereotactic biopsy. Report of 2 cases.
    Moriuchi S; Yamada K; Dehara M; Teramoto Y; Soda T; Imakita M; Taneda M
    J Neurosurg; 2011 Aug; 115(2):278-80. PubMed ID: 21548751
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cordectomy as final treatment option for diffuse intramedullary malignant glioma using 5-ALA fluorescence-guided resection.
    Ewelt C; Stummer W; Klink B; Felsberg J; Steiger HJ; Sabel M
    Clin Neurol Neurosurg; 2010 May; 112(4):357-61. PubMed ID: 20061079
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MRI of pleomorphic xanthoastrocytoma: case report.
    Mascalchi M; Muscas GC; Galli C; Bartolozzi C
    Neuroradiology; 1994 Aug; 36(6):446-7. PubMed ID: 7991088
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pleomorphic xanthoastrocytoma.
    Fernandez D; Muranjan MN; Bavdekar SB; Kantharia V; Shenoy A
    Indian Pediatr; 2001 Mar; 38(3):297-300. PubMed ID: 11255312
    [No Abstract]   [Full Text] [Related]  

  • 7. Functional magnetic resonance imaging-guided resection of low-grade gliomas.
    Hall WA; Liu H; Truwit CL
    Surg Neurol; 2005 Jul; 64(1):20-7; discussion 27. PubMed ID: 15993174
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fluorescence of non-neoplastic, magnetic resonance imaging-enhancing tissue by 5-aminolevulinic acid: case report.
    Miyatake S; Kuroiwa T; Kajimoto Y; Miyashita M; Tanaka H; Tsuji M
    Neurosurgery; 2007 Nov; 61(5):E1101-3; discussion E1103-4. PubMed ID: 18091261
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Endoscopic-assisted visualization of 5-aminolevulinic acid-induced fluorescence in malignant glioma surgery: a technical note.
    Rapp M; Kamp M; Steiger HJ; Sabel M
    World Neurosurg; 2014; 82(1-2):e277-9. PubMed ID: 23871813
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fluorescence-guided resection of malignant gliomas using 5-aminolevulinic acid: practical use, risks, and pitfalls.
    Tonn JC; Stummer W
    Clin Neurosurg; 2008; 55():20-6. PubMed ID: 19248665
    [No Abstract]   [Full Text] [Related]  

  • 11. Oligoastrocytoma presenting with intractable epilepsy.
    Hiremath GK; Bingaman WE; Prayson RA; Nair D
    Epileptic Disord; 2007 Sep; 9(3):315-22. PubMed ID: 17884756
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The results of applying the system of neuronavigation in the intracranial surgery].
    Aksiks IA; Sverzhitskis R; Valeĭnis E; Dzelzite S; Kupchs K
    Zh Vopr Neirokhir Im N N Burdenko; 2003; (2):16-9; discussion 19-20. PubMed ID: 12852000
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Surgery for temporal mediobasal tumors: experience based on a series of 235 patients.
    Schramm J; Aliashkevich AF
    Neurosurgery; 2007 Feb; 60(2):285-94; discussion 294-5. PubMed ID: 17290179
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intraoperative confocal microscopy in the visualization of 5-aminolevulinic acid fluorescence in low-grade gliomas.
    Sanai N; Snyder LA; Honea NJ; Coons SW; Eschbacher JM; Smith KA; Spetzler RF
    J Neurosurg; 2011 Oct; 115(4):740-8. PubMed ID: 21761971
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 5-ALA fluorescence-assisted surgery in pediatric brain tumors: report of three cases and review of the literature.
    Barbagallo GM; Certo F; Heiss K; Albanese V
    Br J Neurosurg; 2014 Dec; 28(6):750-4. PubMed ID: 24799277
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Fluorescence-guided surgery with 5-aminolevulinic acid for resection of malignant gliomas--a new treatment modality].
    Cortnum S; Laursen R
    Ugeskr Laeger; 2013 Feb; 175(9):570-3. PubMed ID: 23608006
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Δ-aminolevulinic acid-induced fluorescence unmasks biological intratumoral heterogeneity within histologically homogeneous areas of malignant gliomas.
    Moiyadi AV; Sridhar E
    Acta Neurochir (Wien); 2015 Apr; 157(4):617-9. PubMed ID: 25577452
    [No Abstract]   [Full Text] [Related]  

  • 18. Melanotic differentiation in dysembryoplastic neuroepithelial tumor.
    Elizabeth J; Bhaskara RM; Radhakrishnan VV; Radhakrishnan K; Thomas SV
    Clin Neuropathol; 2000; 19(1):38-40. PubMed ID: 10774951
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gross total resection rates in contemporary glioblastoma surgery: results of an institutional protocol combining 5-aminolevulinic acid intraoperative fluorescence imaging and brain mapping.
    Schucht P; Beck J; Abu-Isa J; Andereggen L; Murek M; Seidel K; Stieglitz L; Raabe A
    Neurosurgery; 2012 Nov; 71(5):927-35; discussion 935-6. PubMed ID: 22895402
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Supraorbital trans-eyebrow craniotomy and fluorescence-guided resection of fronto-basal high grade gliomas.
    Prat-Acín R; Galeano-Senabre I; Pancucci G; Evangelista R; Ayuso-Sacido A; Botella C
    Clin Neurol Neurosurg; 2013 Sep; 115(9):1586-90. PubMed ID: 23453153
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 28.